Sweden· SE-20140314000069
Gardasil 9 Injektionsvätska, suspension
A medicinal product containing human papillomavirus type 11 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, human papillomavirus type 16 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, human papillomavirus type 18 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, human papillomavirus type 6 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, amorphous aluminium hydroxyphosphate sulphate, registered in Sweden by Merck Sharp & Dohme BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3c-5 (Strain 1895)) By Rdna, Human Papillomavirus Type 16 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3c-5 (Strain 1895)) By Rdna, Human Papillomavirus Type 18 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3c-5 (Strain 1895)) By Rdna, Human Papillomavirus Type 6 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3c-5 (Strain 1895)) By Rdna, Amorphous Aluminium Hydroxyphosphate Sulphate
- Manufacturer
- Merck Sharp & Dohme BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140314000069
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea2ba077-bfa2-403d-a742-4cb3d7435e92 GET /v1/drugs/ea2ba077-bfa2-403d-a742-4cb3d7435e92?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20140314000069",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140314000069",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/gardasil-9-epar-product-information_sv.pdf"
}See everything about human papillomavirus type 11 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, human papillomavirus type 16 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, human papillomavirus type 18 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, human papillomavirus type 6 l1 protein - adsorbed - in the form of virus-like particles produced in yeast cells (saccharomyces cerevisiae canade 3c-5 (strain 1895)) by rdna, amorphous aluminium hydroxyphosphate sulphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.